Risk factors
Bio-Techne (TECH) risk factors
Item 1A of every Bio-Techne Corp. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2026 10-K risk factors29 risks5 new3 reworded
The proposed Merck KGaA acquisition adds deal-completion, regulatory, shareholder-vote and $73-per-share transaction risks.
Filed Aug 24, 2026 - FY2025 10-K risk factors24 risks
International sales drive 44% of revenue, exposing Bio-Techne to global trade and geopolitical tensions. Acquisition strategy and integration risks are critical for growth in Protein Sciences. Heavy reliance on internal manufacturing and third-party cold-chain delivery creates operational vulnerabilities.
Filed Aug 22, 2025